Zoetis Inc logo

Zoetis Inc - Class A

11
2
NYSE:ZTS (USA)   Class A
$ 158.42 +5.06 (+3.3%) 10:08 PM EST
31.25
P/B:
14.53
Market Cap:
$ 72.39B
Enterprise V:
$ 77.11B
Volume:
4.77M
Avg Vol (2M):
4.00M
Also Trade In:
Volume:
4.77M
Avg Vol (2M):
4.00M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Zoetis Inc ( ) from 2013 to Apr 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Zoetis stock (ZTS) PE ratio as of Apr 28 2024 is 31.25. More Details

Zoetis Inc (ZTS) PE Ratio (TTM) Chart

To

Zoetis Inc (ZTS) PE Ratio (TTM) Historical Data

Total 1217
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Zoetis PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-28 31.3 2024-02-23 38.9
2024-04-26 31.3 2024-02-22 38.8
2024-04-25 30.3 2024-02-21 37.2
2024-04-24 29.8 2024-02-20 36.8
2024-04-23 29.5 2024-02-16 37.2
2024-04-22 28.7 2024-02-15 37.4
2024-04-19 28.9 2024-02-14 36.3
2024-04-18 30.2 2024-02-13 36.2
2024-04-17 30.0 2024-02-12 38.8
2024-04-16 30.2 2024-02-09 38.9
2024-04-15 29.5 2024-02-08 38.6
2024-04-12 29.6 2024-02-07 38.9
2024-04-11 32.1 2024-02-06 38.7
2024-04-10 32.2 2024-02-05 37.5
2024-04-09 33.0 2024-02-02 37.3
2024-04-08 32.7 2024-02-01 37.3
2024-04-05 32.7 2024-01-31 37.0
2024-04-04 32.6 2024-01-30 37.8
2024-04-03 32.1 2024-01-29 38.0
2024-04-02 32.5 2024-01-26 37.8
2024-04-01 32.9 2024-01-25 37.0
2024-03-28 33.4 2024-01-24 36.7
2024-03-27 33.2 2024-01-23 37.1
2024-03-26 32.7 2024-01-22 37.7
2024-03-25 33.1 2024-01-19 37.2
2024-03-22 33.3 2024-01-18 37.6
2024-03-21 33.2 2024-01-17 37.6
2024-03-20 33.7 2024-01-16 38.1
2024-03-19 34.1 2024-01-12 39.2
2024-03-18 33.7 2024-01-11 38.8
2024-03-15 34.0 2024-01-10 39.2
2024-03-14 34.3 2024-01-09 38.6
2024-03-13 34.8 2024-01-08 38.7
2024-03-12 35.8 2024-01-05 38.4
2024-03-11 36.2 2024-01-04 38.3
2024-03-08 35.9 2024-01-03 38.0
2024-03-07 35.8 2024-01-02 38.8
2024-03-06 36.2 2023-12-29 38.9
2024-03-05 36.5 2023-12-28 38.9
2024-03-04 37.0 2023-12-27 40.0
2024-03-01 37.6 2023-12-26 39.7
2024-02-29 39.1 2023-12-22 39.6
2024-02-28 39.4 2023-12-21 39.6
2024-02-27 39.3 2023-12-20 39.6
2024-02-26 38.9 2023-12-19 40.3

Zoetis Inc (ZTS) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.